Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANB Combinations in Sleeve Gastrectomy
NCT06137924Phase 3Unknown
- Sponsor
- Universidad Simón Bolívar
- Start
- Dec 2023
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine, dexamethasone, clonidine and gelofusine + sodium chloride in pain, nausea ((none)) and Vomiting (3 arms), sponsored by Universidad Simón Bolívar. Primary endpoint: Postoperative pain at 36 hours. Status: unknown.
02
Drugs
bupivacainedexamethasoneclonidinegelofusine + sodium chloride
03
Conditions
painnausea ((none))Vomiting
Beyond the preview
Go deeper on NCT06137924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06137924.